NitroMed Inc.'s stock soared 73.1 percent Monday when the firm suggested it could launch BiDil for African-Americans with heart failure one year ahead of schedule, after stopping a confirmatory trial due to favorable preliminary results. (BioWorld Today)

NitroMed Inc.'s stock soared 73.1 percent Monday when the firm suggested it could launch BiDil for African-Americans with heart failure one year ahead of schedule, after stopping a confirmatory trial due to favorable preliminary results. (BioWorld Today)

Genentech Inc. signed a multiyear collaboration with Phenomix Corp. to identify and prioritize drug targets for immune disorders. (BioWorld Today)

Genentech Inc. signed a multiyear collaboration with Phenomix Corp. to identify and prioritize drug targets for immune disorders. (BioWorld Today)